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Abstract: Ligands that have an affinity for protein targets can
be screened very effectively by exploiting favorable properties
of long-lived states (LLS) in NMR spectroscopy. In this work,
we describe the use of LLS for competitive binding experi-
ments to measure accurate dissociation constants of fragments
that bind weakly to the ATP binding site of the N-terminal
ATPase domain of heat shock protein 90 (Hsp90), a therapeutic
target for cancer treatment. The LLS approach allows one to
characterize ligands with an exceptionally wide range of
affinities, since it can be used for ligand concentrations [L]
that are several orders of magnitude smaller than the dissoci-
ation constants KD. This property makes the LLS method
particularly attractive for the initial steps of fragment-based
drug screening, where small molecular fragments that bind
weakly to a target protein must be identified, which is a difficult
task for many other biophysical methods.
Over the last decade, fragment screening has emerged as
a powerful way to identify new lead compounds,[1] and
fragment-based drug discovery (FBDD) has gained wide
acceptance in pharmaceutical industry, as evidenced by
a significant number of fragments that have been developed
into lead series and clinical candidates.[1a,2] For this purpose,
relatively small libraries of carefully chosen compounds with
low molecular weights (120–250 Da) are screened to identify
fragments that can weakly bind to a protein target. Useful
fragments typically have dissociation constants KD ranging
from 0.1 to 10 mm or greater. Structural biology is usually
employed to establish their binding mode and guide their
optimization. Techniques that can detect ligand–protein
complexes, such as X-ray crystallography, surface plasmon
resonance (SPR), isothermal titration calorimetry (ITC), and
high-concentration assays can be used for fragment screening.
The output of these target-based methods depends on the
fraction of bound protein with respect to the total protein
concentration.[3] If the binding affinities are weak, the
equilibrium can only be shifted by increasing the concen-
tration of the fragments, which must therefore be highly
soluble, a requirement that is difficult to meet.
In ligand-based methods the output is given by the
fraction of bound ligands with respect to total ligand
concentration.[3] So despite its low intrinsic sensitivity, the
detection of ligands by NMR spectroscopy can be used over
an extremely wide dynamic range of dissociation constantsKD
while requiring only relatively low protein and ligand
concentrations.[3] In contrast to the above-mentioned bio-
physical techniques, one can perform screening with ligand
concentrations [L] that are orders of magnitude lower than
the corresponding dissociation constantsKD. Among the best-
known NMR methods, one should mention the transfer of
magnetization from the solvent to protein-bound ligands
(“Water-LOGSY”),[4] magnetization transfer from the pro-
tein to the ligand by saturation transfer difference (STD),[5]
the accelerated transverse relaxation of 1H or 19F nuclei
attached to bound ligands measured by Carr–Purcell–Mei-
boom–Gill (CPMG) spin echo sequences, and selective
measurements of relaxation rates of 1H nuclei of bound
ligands.[6] These methods exploit a difference in relaxation
rates between bound and free ligands [Eq. (1)].
DRi ¼ Rboundi  Rfreei ð1Þ
Here i= 1 stands for longitudinal relaxation, i= 2 for trans-
verse relaxation, i= 11 for relaxation in the rotating frame,
i=LLS for long-lived states, i=LLC for long-lived coher-
ences, etc. The difference DRi determines the observed
relaxation rate Robsi
 
, which in the fast-exchange regime[7]
(provided the exchange rates are faster that the difference in
chemical shifts) is a weighted average of Rboundi and R
free
i
determined by the molar fractions [Eq. (2)].
Robsi
  ¼ Rboundi Xbound þ Rfreei X free ð2Þ
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The larger DRi, the smaller the molar fraction X
bound=
[PL]/[L] that can be detected. The experimental conditions
must be chosen to yield a sufficiently large contrast Ci
[Eq. (3)].
Ci ¼
Robsi Rfreei
Robsi
100% ð3Þ
It has been proposed recently that LLS can be used for
ligand–protein screening.[8] The difference DRLLS can be much
larger than DR1, DR2, etc., so that it is possible to achieve
a high contrast CLLS even for high ligand/protein ratios,
making LLS-based screening particularly attractive for a frag-
ment-based approach that seeks to identify weakly binding
ligands.
LLS are nuclear spin states that are immune to dipole–
dipole interactions between the two spins involved.[9] As their
name implies, LLS have the property that their magnetization
decays with a low rate constant RLLS that is often much
smaller than the longitudinal relaxation rate R1. Ratios R1/
RLLS up to 37 have been measured for pairs of protons,
[10]
making LLS valuable probes to study slow diffusion[11] and
slow exchange phenomena[12] and to preserve hyperpolariza-
tion induced by DNP.[13] It has been shown that even a small
change of the chemical shifts of the nuclei that carry the LLS
upon binding can boostRboundLLS , and hence increase the contrast
CLLS, since the radio-frequency (rf) field that must be applied
to sustain the LLS becomes inefficient if it is not applied
exactly halfway between the two chemical shifts. The
combination of a large contrast CLLS and a slow relaxation
rate RfreeLLS< R
free
1 makes the dynamic range of LLS screening
particularly attractive, since one can detect the binding of
fragments with dissociations constants KD that cover a wide
range. In this work we demonstrate that it is possible to
measure dissociation constants up to 12 mm, where all other
known biophysical techniques fail, including conventional
NMR methods based on the observation of ligands.
To illustrate the advantages of LLS screening, we
determined the contrast CLLS for the LLS signals of the
aromatic protons I and S of vanillic acid diethylamide
(ligand II), represented by bold red letters H in Figure 1,
during a titration against the N-terminal ATPase domain of
heat shock protein 90 (Hsp90). Excitation of long-lived states
(LLS) was achieved as described by Sarkar et al.[10] Three
nonselective “hard” pulses 908t1808t458 were used to
generate zero-quantum coherences and 2IzSz terms. A
monochromatic continuous-wave (CW) radio-frequency
field (rf) was applied during a delay D exactly halfway
between the two chemical shifts[8] to render the two spins I
and S magnetically equivalent. When this rf field is effective,
the dipolar interaction between spins I and S does not
contribute to the LLS relaxation, henceRLLS< R1. Finally, two
more pulses 458t1808t convert the LLS into observable
Iy and Sy terms.
Table 1 shows mole fractions Xbound of bound ligands for
different ligand/protein ratios and the corresponding contrast
CLLS. Even for a large ligand-to-protein ratio [L]tot/[P]tot= 272,
one observes a dramatic 45% contrast.
A contrast CLLS= 23%, corresponding to a ratio R
obs/
Rfree= 1.3 could be achieved with a ratio [L]tot/[P]tot= 707, in
other words, under conditions where less than 0.2% of the
ligand was bound to the protein. Compared to other 1H-
detected NMR methods, which suffer from lower contrast,
this method allows ligand binding to be detected for low
protein concentrations and/or low binding affinities. One can
thus more easily adjust the concentrations of proteins and
ligands to study very weak affinities in screening assays. For
example, to detect ligands with KD 1 mm and [L]= 500 mm,
one would require a protein concentration [P]= 3 mm ; alter-
natively, if [P]= 20 mm one can detect binding if KD> 10 mm.
Such weak affinities are typically encountered for fragments
that bind protein–protein interfaces. This offers considerable
advantages over fragment screening by traditional ligand-
based NMR methods.
Long-lived states (LLS) can be best excited within
isolated two-spin systems, although larger spin systems can
also support LLS.[14] Many small fragments contain suitable
pairs of 1H or 19F nuclei. LLS screening is most effectively run
in competition mode, as proposed by Dalvit et al.[15] for
traditional R1 and R2 experiments: a strongly binding ligand
Figure 1. Weakly binding ligands for the ATP binding site of heat shock
protein 90 (Hsp90). Pairs of protons that are suitable for the excitation
of LLS are indicated by bold red letters.
Table 1: Molar fractions of bound ligands for different ligand/protein
ratios and experimentally observed contrast CLLS for a titration of vanillic
acid diethylamide (ligand II, KD=790 mm) in the presence of the protein
Hsp90.
[L]tot/[P]tot X
bound [mol%] Contrast CLLS [%]
56 0.74 72
125 0.49 63
202 0.36 54
272 0.28 45
366 0.22 41
548 0.16 29
707 0.13 23
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partly displaces a weakly binding “spy” ligand from the
binding site, so that one observes a decrease of the relaxation
rate RLLS of the displaced spy ligand. Thus, it is possible to
determine the affinity of strongly binding ligands by monitor-
ing the rate RLLS of a spy ligand. Furthermore, by keeping the
concentration of the spy ligand low, one can study competing
ligands with limited solubility. This is a major advantage not
only for screening mixtures, but also for determining the
affinities of weakly binding fragments.
Prior to starting a fragment screening campaign, a small
number of fragments are typically screened using different
NMR methods. The NMR assay can then be customized to
a specific protein target. During this phase a number of hits
may be identified so that one can select a spy ligand that is
suitable for competitive screening. To show the applicability
of the method, we measured relaxation rates RLLS in a group
of three ligands that were known to bind Hsp90 in its ATP
binding site, located in the N-terminal ATPase domain of the
protein.[16] Adenosine diphosphate (ADP, ligand I) is the
product of the ATPase reaction. Vanillic acid diethylamide
(ligand II) and 2-aminopyrimidine (ligand III) have been
identified as weakly binding ligands by fragment screening.[16]
LLS experiments were performed by focusing attention
on pairs of scalar-coupled protons in these three compounds
(in bold red letters in Figure 1). The two diastereotopic
protons H5 and H5’ of the ribose group were selected to
excite LLS in ADP, while pairs of aromatic protons were
selected for compound II (for ligand III, we could not excite
any LLS with a useful ratio R1/RLLS> 1). To measure the rates
RboundLLS , direct titration curves were measured for 0.3 mm<
[L]tot< 6 mm in the presence of [P]tot= 10 mm Hsp90. The
curves were fitted to the following function[17] given in
Equation (4) to extract KD and R
bound
LLS .
RobsLLS
  ¼ PL½ 
L½ tot R
bound
LLS  RfreeLLS
 þ RfreeLLS ð4Þ
Here the ratio [PL]/[L]tot is a function of the dissociation
constant KD.
[17] Table 2 also gives dissociation constants KD
determined by isothermal titration calorimetry (ITC)[16] for
comparison.
The equilibrium constants determined by LLS and ITC
are in fair agreement. In order to detect fragments with
100 mm<KD< 10 mm in competitive binding experiments, the
weakest ligand (ligand II) that could be identified by ITC was
chosen as a spy molecule. Figure 2 shows the LLS signals of
ligand II in the absence (top) and in the presence (middle) of
Hsp90. When Astexs clinical Hsp90 inhibitor AT13387 is
added (bottom), the signal is almost completely restored,
demonstrating that both ligand II and the high-affinity
inhibitor bind Hsp90 to the same ATP binding site.
If a library of, say, 1000 compounds is to be screened
against a protein target, it is most efficient to screen “cock-
tails” containing typically three to ten ligands, to reduce
experimental time and protein consumption. We tested the
performance of LLS screening in competition mode with
a mixture containing known binders and known nonbinders.
Ligands V, VI, and VII (see Figure 3) had previously been
identified as weak ADP-competitive binders during a screen-
ing campaign at Astex.[16]
In the absence of competing binders, the interaction
between the spy ligand and the protein leads to rapid LLS
relaxation and hence to the attenuation of the LLS signal
(spectrum 1 in Figure 4); conversely, the presence of a com-
petitor leads to a partial displacement of the spy ligand, hence
to slower LLS relaxation and a partial restoration of the LLS
signal of the spy (spectrum 2 in Figure 4). This change in LLS
Table 2: Dissociation constants KD determined by LLS and ITC, and rates
RLLS for bound and free ligands I and II in the presence of Hsp90.
Ligand KD [mm] LLS KD [mm] ITC R
bound
LLS [s
1] RfreeLLS [ms
1]
I 1510 10 776 7317
II 70897 790 943 22811
III[a] – >1000 – –
[a] For ligand III no useful LLS signal could be observed.
Figure 2. LLS NMR spectra of ligand II in three different solutions,
sustaining the LLS for a delay D=2.5 s: 1) 500 mm ligand II in the
absence of Hsp90; 2) 500 mm ligand II in the presence of 10 mm
Hsp90; 3) 500 mm ligand II in the presence of 10 mm Hsp90 and 10 mm
AT13387. In the latter case, ligand II is partly expelled from the ATP
binding site of Hsp90 so that its LLS signal is partly restored.
Figure 3. Fragments identified by LLS as weak binders for Hsp90.
Their dissociation constants KD were measured for the first time by
LLS, as described in the text and Table 3.
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signal is due to a mere 13% change in the amount of bound
ligand, which itself is only 0.3% of the total ligand concen-
tration.
Once the presence of a binder in a mixture has been
demonstrated, a deconvolution step is needed to identify the
hit, as shown in Figure 4, which allowed the identification of
3-hydroxyindazole as a weak binder for Hsp90.
Note that to displace a weak spy ligand by even more
weakly binding fragments, the latter must be present at
similar concentrations. This is a considerable advantage over
other NMR methods used in competition mode, which
because of the lower contrast require much higher protein
concentrations to achieve effective displacements, as they
require small ligand/protein ratios in order to detect weak
ligands.
Furthermore, if the mixtures comprise many components,
the NMR resonances of the spy molecule may be obscured by
overlapping signals,[18] which may hamper other NMR
methods when used in competition mode. Fortunately, the
LLS sequence in effect eliminates signals that do not stem
from long-lived states. As shown by spectrum 2 in Figure 4,
resonances that arise from other compounds are considerably
reduced, compared to the conventional 1H spectrum of the
same mixture (spectrum 4). The problem could be further
reduced by selecting a spy ligand with a larger difference in
chemical shifts, in order to decrease the likelihood that the
two doublets stemming from the LLS overlap with other
signals.
Once weak binders have been identified, their dissocia-
tion constants KD can be determined from K
app
D of the spy
molecule upon titration of the spy ligand in the presence of
a constant amount of a weak binder or vice versa.[15] Titration
of a spy ligand makes it possible to use the same experimental
setup for different fragments. The highest concentrations of
the competing ligands are limited only by their aqueous
solubility. At each concentration, the rates RLLS can be
obtained from the ratio of LLS signal intensities observed
with two different sustaining delays ta and tb. In order to
verify that our procedures are self-consistent, the dissociation
constantKD of ADP (ligand I) was determined by monitoring
RLLS in vanillic acid diethylamide (ligand II) while titrating
500 mm< [LII]< 5 mm with 10 mm Hsp90 and a fixed ADP
concentration [LI]= 15 mm. The resulting KD(LI)= 8 3 mm is
in reasonable agreement with KD(LI)= 15 10 mm deter-
mined by direct titration of ADP (ligand I) against Hsp90
(Table 2). Following a similar procedure, the affinity of 2-
aminopyrimidine (ligand III) (Figure 5) was determined with
10 mm Hsp90, using a fixed concentration [LIII]= 7 mm, and
titrating 500 mm< [LII]< 5 mm. The fitted dissociation con-
stant KD(LIII)= 11 2 mm suggests very weak binding of this
ligand to the protein, which must, however, clearly be specific
to explain these observations. The fragment bound to Hsp90
was also observed by X-ray crystallography, as reported by
Murray et al.[16]
This approach was used to measure the dissociation
constants KD of the four fragments shown in Figure 2. The
values derived from full titrations and from experiments with
a single concentration are in good agreement (Table 3).The
Figure 4. Identification of a weak binder in a mixture. 1) Weak LLS
signals of the spy ligand after sustaining the LLS for D=2.5 s in the
absence of a competing binder in mixture 1 (spy ligand [II]=500 mm
with KD=790 mm protein [Hsp90]=2.5 mm and three nonbinding
ligands: 600 mm tyrosine, 600 mm 3,4-difluorobenzylamine, and 600 mm
4-trifluoromethylbenzamidine). 2) Enhanced LLS signals in the pres-
ence of a weak binder (mixture 2 contains 600 mm of the weakly
binding ligand [V] 3-bromo-5-methylpyridin-2-ylamine (KD=2.2 mm),
instead of 600 mm of the nonbinding ligand 3,4-difluorobenzylamine).
3) LLS signals observed in the presence of only the binding fragment
(mixture 3 contains 500 mm spy ligand [II], 2.5 mm protein [Hsp90],
and 600 mm of the weakly binding ligand [V] 3-bromo-5-methylpyridin-
2-ylamine). 4) Conventional 1H NMR spectrum of mixture 2.
Figure 5. Gray line: Direct titration of vanillic acid diethylamide (ligan-
d II) in the presence of 10 mm Hsp90 protein. Black line: Competition
experiment with titration of vanillic acid diethylamide (ligand II) as
a spy ligand in the presence of 10 mm Hsp90 protein and a constant
concentration of 7 mm of 2-aminopyrimidine (ligand III).
Table 3: Dissociation constants of fragments measured by LLS com-
petition binding experiments.
Ligand KcompD [mm] K
comp
D [mm]
(from first point
of titration)
Concentration [L]
of competing
ligands (mM)
I 0.0080.003 0.010 0.015
II (spy) – –
III 112 12 7
IV 0.90.2 0.7 0.9
V 1.40.9 2.2 1
VI 1.70.9 2.2 1.6
VII 71 5 2.9
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latter procedure is to be preferred when fragment hits are
ranked according to affinity after a screening campaign.
Note that the choice of the spy molecule determines the
experimental conditions of the LLS assay. With our choice of
a spy molecule (ligand II, KD= 790 mm), a concentration of
7 mm of the competing ligand III (KD= 12 mm) gives rise to
19% contrast (first point of black curve in Figure 5). This can
be reduced to 3.3 mm to give rise to a 10% contrast, which is
sufficient to show binding in screening experiments, as shown
in Figure 4 for ligand V (difference between spectra 1 and 2).
If the expected affinities of fragments for a particular target
are on the order ofKD= 5 mm or higher, it is most convenient
to identify and use a weaker spy molecule that would ensure
a 10% contrast while working at lower fragment concen-
trations [see Eq. (4)]. As a consequence, one can effectively
screen and identify weak fragments with very low solubility.
In summary, the detection of LLS requires ligands that
contain a (preferably isolated) two-spin system, a condition
that cannot easily be fulfilled for all fragments in a screening
“cocktail”. We have therefore shown that the LLS method
can be used very effectively in a competitive approach, where
the displacement of a suitable spy molecule is detected
through the effect on its LLS. We have demonstrated that
such LLS-filtered competition experiments can be used to
screen and determine the binding constants of very weakly
binding fragments with KD up to 12 mm by using ligand/
protein ratios as large as 200. This advantage can be put to
good use by reducing the concentration of the target protein,
thus extending the sensitivity of detection compared to
established NMR screening methods like LOGSY, STD,
and T11. A sufficient contrast can be achieved with ligand/
protein ratios up to 700, which makes it possible to detect the
binding of fragments with KD= 790 mm. Alternatively, the
ability to detect the presence of very small concentrations of
protein–ligand complexes can be used to determine very
weak binding (KD> 10 mm), which facilitates the screening of
fragments for challenging protein targets. We have also shown
that we can quantitatively determine the dissociation con-
stants of a spy molecule and various competing ligands. The
ability to measure accurate binding constants in themm range,
where methods such ITC and high concentration assays may
fail, in particular when the ligand solubility is limited, enables
the investigation of structure–activity relationships and the
guidance of initial steps of hit-optimization chemistry.
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